INS and cancer: This reflects the diverse role of ESR1 on tissue context, which acts as a metabolic regulator in diabetes, potentially improving insulin sensitivity and glucose homeostasis through estrogen signaling effects on pancreatic beta-cells and adipose tissue [51] but can function as a tumor promoter in cancers like hepatocellular carcinoma [52].